CRISPR Therapeutics AG (CRSP)
44.17
-1.01 (-2.24%)
USD |
NASDAQ |
Mar 30, 16:00
44.28
+0.11 (+0.25%)
After-Hours: 19:42
CRISPR Therapeutics Total Return Level: 45.18 for March 29, 2023
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
March 29, 2023 | 45.18 |
March 28, 2023 | 43.85 |
March 27, 2023 | 44.35 |
March 24, 2023 | 43.43 |
March 23, 2023 | 43.14 |
March 22, 2023 | 43.54 |
March 21, 2023 | 45.06 |
March 20, 2023 | 44.46 |
March 17, 2023 | 45.74 |
March 16, 2023 | 45.39 |
March 15, 2023 | 44.92 |
March 14, 2023 | 45.15 |
March 13, 2023 | 45.72 |
March 10, 2023 | 43.22 |
March 09, 2023 | 45.79 |
March 08, 2023 | 47.93 |
March 07, 2023 | 47.84 |
March 06, 2023 | 49.33 |
March 03, 2023 | 50.84 |
March 02, 2023 | 49.19 |
March 01, 2023 | 47.72 |
February 28, 2023 | 49.32 |
February 27, 2023 | 49.16 |
February 24, 2023 | 48.02 |
February 23, 2023 | 50.04 |
Date | Value |
---|---|
February 22, 2023 | 50.38 |
February 21, 2023 | 46.63 |
February 17, 2023 | 50.89 |
February 16, 2023 | 50.54 |
February 15, 2023 | 52.17 |
February 14, 2023 | 50.87 |
February 13, 2023 | 51.51 |
February 10, 2023 | 49.78 |
February 09, 2023 | 51.08 |
February 08, 2023 | 53.39 |
February 07, 2023 | 55.66 |
February 06, 2023 | 55.51 |
February 03, 2023 | 55.27 |
February 02, 2023 | 56.12 |
February 01, 2023 | 52.33 |
January 31, 2023 | 51.02 |
January 30, 2023 | 49.96 |
January 27, 2023 | 52.78 |
January 26, 2023 | 50.47 |
January 25, 2023 | 50.75 |
January 24, 2023 | 51.96 |
January 23, 2023 | 51.32 |
January 20, 2023 | 49.61 |
January 19, 2023 | 47.67 |
January 18, 2023 | 50.55 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
22.73
Minimum
Dec 21 2018
210.04
Maximum
Jan 14 2021
71.05
Average
59.69
Median
Total Return Level Benchmarks
Vertex Pharmaceuticals Inc | 314.24 |
Intellia Therapeutics Inc | 37.56 |
Beam Therapeutics Inc | 31.02 |
Moderna Inc | 148.80 |
Editas Medicine Inc | 7.41 |